Back
DXP Enterprises 10K Form
Buy
65
DXPE
DXP Enterprises
Last Price:
35.74
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-10 | 10Q | DXPE/DXP Enterprises Quarterly |
2020-08-10 | 10Q | DXPE/DXP Enterprises Quarterly |
2020-05-08 | 10Q | DXPE/DXP Enterprises Quarterly |
2020-03-13 | 10K | DXPE/DXP Enterprises Annual |
2019-11-07 | 10Q | DXPE/DXP Enterprises Quarterly |
2019-08-07 | 10Q | DXPE/DXP Enterprises Quarterly |
Receive DXPE News And Ratings
See the #1 stock for the next 7 days that we like better than DXPE
DXPE Financial Statistics
Sales & Book Value
Annual Sales: | $1.48B |
---|---|
Cash Flow: | $-4.25M |
Price / Cash Flow: | 42.47 |
Annual Sales: | $22.01 |
Price / Book: | 1.59 |
Profitability
EPS (TTM): | 3.09000 |
---|---|
Net Income (TTM): | $57.72M |
Gross Margin: | $422.04M |
Return on Equity: | 15.42% |
Return on Assets: | 5.65% |
DXP Enterprises Earnings Forecast
Key DXP Enterprises Financial Ratios
- The Gross Profit Margin over the past 27 years for DXPE is 28.50%.
- The Selling, General & Administrative Expenses for DXPE have been equal to 21.90% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 60.51% of Operating Income.
- The Net Earning history of DXPE is 3.25% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 19 years.
DXP Enterprises Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Industrial Distribution |
Sector: | Industrials |
Current Symbol: | DXPE |
CUSIP: | 233377 |
Website: | dxpe.com |
Debt
Debt-to-Equity Ratio: | 1.12 |
---|---|
Current Ratio: | 2.45 |
Quick Ratio: | 1.87 |
Price-to-Earnings
Trailing P/E Ratio: | 14.18 |
---|---|
Forward P/E Ratio: | 8.42 |
DXPE Technical Analysis vs Fundamental Analysis
Buy
65
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy or a Sell?
-
DXP Enterprises stock is rated a Buy
The current DXP Enterprises [DXPE] share price is $35.02. The Score for DXPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.